TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Belach Bioteknik AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
10,080
|
7,470
|
30,085 |
| Financial expenses |
69
|
35
|
36 |
| Earnings before taxes |
-441
|
-1,998
|
5,372 |
| EBITDA |
-358
|
-1,867
|
5,499 |
| Total assets |
10,420
|
11,578
|
13,449 |
| Current assets |
7,776
|
8,867
|
12,985 |
| Current liabilities |
800
|
1,648
|
2,263 |
| Equity capital |
9,335
|
9,604
|
10,567 |
| - share capital |
516
|
507
|
473 |
| Employees (average) |
5
|
5
|
5 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
89.6%
|
83.0%
|
78.6% |
| Turnover per employee |
2,016
|
1,494
|
6,017 |
| Profit as a percentage of turnover |
-4.4%
|
-26.7%
|
17.9% |
| Return on assets (ROA) |
-3.6%
|
-17.0%
|
40.2% |
| Current ratio |
972.0%
|
538.0%
|
573.8% |
| Return on equity (ROE) |
-4.7%
|
-20.8%
|
50.8% |
| Change turnover |
2,475
|
-24,749
|
16,679 |
| Change turnover % |
33%
|
-77%
|
124% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.